LMR Partners’s The Oncology Institute Warrant TOIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71K Hold
1,624,856
﹤0.01% 1284
2025
Q4
$196K Hold
1,624,856
﹤0.01% 1278
2025
Q3
$195K Hold
1,624,856
﹤0.01% 1215
2025
Q2
$83.4K Hold
1,624,856
﹤0.01% 1186
2025
Q1
$44K Hold
1,624,856
﹤0.01% 1204
2024
Q4
$8.45K Buy
+1,624,856
New +$25.3K ﹤0.01% 1122
2024
Q3
Sell
-1,624,856
Closed -$32.2K 1523
2024
Q2
$42.7K Hold
1,624,856
﹤0.01% 940
2024
Q1
$325K Hold
1,624,856
﹤0.01% 811
2023
Q4
$325K Buy
1,624,856
+31,500
+2% +$4.98K ﹤0.01% 692
2023
Q3
$146K Buy
1,593,356
+24,792
+2% +$2.02K ﹤0.01% 654
2023
Q2
$43.8K Hold
1,568,564
﹤0.01% 675
2023
Q1
$1.06M Buy
1,568,564
+99,100
+7% +$12.2K 0.02% 564
2022
Q4
$2.42M Buy
1,469,464
+262,954
+22% +$85.8K 0.04% 470
2022
Q3
$5.59M Buy
1,206,510
+10,124
+0.8% +$7.05K 0.1% 244
2022
Q2
$6.05M Buy
1,196,386
+172,395
+17% +$159K 0.1% 240
2022
Q1
$7.3M Buy
1,023,991
+858,573
+519% +$780K 0.08% 243
2021
Q4
$1.61M Buy
+165,418
New +$205K 0.02% 541

Other funds holding TOIIW

LMR Partners's TOIIW Position: Q1 2026 in Review

LMR Partners held its The Oncology Institute Warrant (TOIIW) position steady in Q1 2026 at 1,624,856 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #1284.

LMR Partners first reported a position in TOIIW in Q4 2021 and has held it in 17 quarters since. The position peaked at $7.3M in Q1 2022. 11 funds tracked by Wall St. Rank hold TOIIW as of Q1 2026.

  • LMR Partners held 1,624,856 shares of The Oncology Institute Warrant worth $71K as of Q1 2026.
  • LMR Partners left its The Oncology Institute Warrant share count unchanged in Q1 2026.
  • The Oncology Institute Warrant made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1284 holding.
  • LMR Partners first reported a position in The Oncology Institute Warrant in Q4 2021 and has held it in 17 quarters since.
  • LMR Partners's The Oncology Institute Warrant position peaked at $7.3M in Q1 2022.
  • 11 funds tracked by Wall St. Rank held The Oncology Institute Warrant as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.